Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

A Dyadic Sleep Intervention for Alzheimer's Disease Patients and Their Caregivers

Lead Sponsor:

University of California, Los Angeles

Conditions:

Sleep

Alzheimer Disease

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

Studies consistently show the negative health impact of sleep problems in both Alzheimer's disease (AD) patients and their caregivers. However, only a few sleep interventions have been conducted for A...

Detailed Description

In 2015, Americans provided 18 billion hours of unpaid care for patients with Alzheimer's disease (AD) and other dementias, with an economic value of $221 billion. This estimate may be even higher amo...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Alzheimer's disease (AD) patients:
  • AD diagnosis OR probable or possible AD as documented in electronic medical record, which includes Mini Mental State Exam score \>12 (indicating mild to moderate severity of AD) and neuroimaging evidence
  • Community-dwelling
  • \>1 sleep problem \>3x/week on the Neuropsychiatric Inventory Nighttime Behavior Scale
  • Aged \>60 years
  • Able to ambulate with or without assistive device
  • Have an eligible caregiver (see below)
  • Inclusion Criteria for caregivers:
  • Live with an eligible patient
  • Aged \>21 years
  • Have regularly assisted patient with \>1 of 6 basic activities of daily living (ADLs) (i.e., bathing, dressing, toileting, transfers, continence, feeding) or \>1 of 8 Instrumental ADL (IADLs) (i.e., using the telephone, shopping, preparing meals, housekeeping, laundry, transportation, taking medicine, managing money) for the past 6 months
  • Pittsburgh Sleep Quality Index (PSQI) total score \>5
  • Montreal Cognitive Assessment (MoCA) score \>= 23
  • Can communicate in English
  • Exclusion Criteria:
  • \- If AD patient is bed bound

Exclusion

    Key Trial Info

    Start Date :

    September 11 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    February 1 2023

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT03455569

    Start Date

    September 11 2018

    End Date

    February 1 2023

    Last Update

    July 12 2024

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    University of California Los Angeles

    Los Angeles, California, United States, 90095

    2

    Veterans Affairs Greater Los Angeles Healthcare System

    North Hills, California, United States, 91343